USD 7.41
(19.71%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 109.51 Million USD | -18.09% |
2022 | 133.7 Million USD | -27.71% |
2021 | 184.96 Million USD | 41.79% |
2020 | 130.44 Million USD | -83.29% |
2019 | 780.74 Million USD | 12.54% |
2018 | 693.72 Million USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q3 | 132.93 Million USD | 2.29% |
2024 Q1 | 125.02 Million USD | 14.16% |
2024 Q2 | 129.95 Million USD | 3.94% |
2023 Q1 | 136.22 Million USD | 1.89% |
2023 FY | 109.51 Million USD | -18.09% |
2023 Q4 | 109.51 Million USD | -5.02% |
2023 Q3 | 115.3 Million USD | -10.26% |
2023 Q2 | 128.48 Million USD | -5.68% |
2022 Q2 | 137.58 Million USD | -10.08% |
2022 Q1 | 153.01 Million USD | -17.27% |
2022 FY | 133.7 Million USD | -27.71% |
2022 Q4 | 133.7 Million USD | 5.34% |
2022 Q3 | 126.92 Million USD | -7.74% |
2021 FY | 184.96 Million USD | 41.79% |
2021 Q4 | 184.96 Million USD | -0.93% |
2021 Q3 | 186.69 Million USD | 87.3% |
2021 Q2 | 99.67 Million USD | -6.66% |
2021 Q1 | 106.78 Million USD | -18.14% |
2020 Q1 | 114.36 Million USD | -85.35% |
2020 Q4 | 130.44 Million USD | 11.24% |
2020 Q3 | 117.26 Million USD | 2.21% |
2020 Q2 | 114.73 Million USD | 0.32% |
2020 FY | 130.44 Million USD | -83.29% |
2019 FY | 780.74 Million USD | 12.54% |
2019 Q4 | 780.74 Million USD | 0.0% |
2018 FY | 693.72 Million USD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Doximity, Inc. | 177.97 Million USD | 38.465% |
Evolent Health, Inc. | 1.61 Billion USD | 93.209% |
MultiPlan Corporation | 5.39 Billion USD | 97.971% |
Phreesia, Inc. | 119.63 Million USD | 8.456% |
Teladoc Health, Inc. | 2.06 Billion USD | 94.7% |
Veeva Systems Inc. | 1.26 Billion USD | 91.35% |